Pharm Friday: Pipe’s become slipperier

This drug is currently being used for preventing clots in knee and hip replacement patients, however was studied for its effects on preventing stroke in atrial fibrillation. The drug was found to be more effective without the need for close monitoring than its predecessor Warfarin.

While not on the market for cardiac patients yet, there is speculations of its release as early as September.

The answer to last weeks question: Gravol (Dimenhydrenate)

Read more:







This entry was posted in Pharmacology. Bookmark the permalink.

Leave a Reply

Your email address will not be published.


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>